Advancing Treatment for B-cell Acute Lymphoblastic Leukemia
Tisagenlecleucel, a chimeric antigen receptor (CAR) T-cell immunotherapy, demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia, according to recent findings.
Three Feinberg Faculty Elected to National Academy of Medicine
Elizabeth McNally, MD, PhD; Melissa Simon, MD, MPH; and Guillermo Ameer, ScD; have been elected to the National Academy of Medicine.
Clements Receives Lifetime Achievement Award from IAFP
Deborah Smith Clements, MD, received the Illinois Academy of Family Physician’s Distinguished Service Award.